dsip portal Predict, Optimize, Recommend, and Track

The results reported in Huntingtons disease from a randomized, placebo-controlled study, which examines both efficacy and safety of MEM during long-term administration (52 weeks) in non-demented multiple sclerosis patients, were negative for cognitive impairment improvement

Quality documentation Third-party tested batch-specific results 99.9%purity Batch COA PDF not linked yet for this variant

Both are commonly compared in bio-hacking communities because theyre both synthetic, intranasally administered, and target the central nervous system to improve mental performance, all the while offering very distinct benefits

This is why the 3-month cycle framework exists and why a single injection produces minimal results compared to a structured protocol

Grant, A

PMID 12354393